Clinical Trials
Study Title:
Randomized Phase II Trial of Postoperative Adjuvant Capecitabine and Temozolomide Versus Observation in High Risk Pancreatic Neuroendocrine Tumors
|
For more information about the trial above please contact the study team:
Medical University of South Carolina
Principal Investigator, William Lancaster, at lancastw@musc.edu.
Study Coordinator, Bria Sanders, at sandebri@musc.edu.
Trial opened at the following institutions: Medical University of South Carolina |